Pfizer, BioNTech seek to broaden late-stage COVID-19 injection test

0
2
Loading ....

Pfizer and also BioNTech are wanting to broaden the registration of their Stage 3 COVID-19 injection test to approximately about 44,000 individuals after sending a proposition to the Food and also Medicine Administra …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here